Karnataka High Court refuses to quash case over substandard calcium and vitamin D3 tablets

The Karnataka High Court has refused to quash criminal proceedings under the Drugs and Cosmetics Act, 1940 against a pharmaceutical company and its managing partner over calcium and vitamin D3 tablets found Not of Standard Quality after testing. The company argued that a sample seized on February 18, 2020 and sent for testing on February 20, 2020 breached the Act, which requires samples to be sent forthwith. In its order of November 2, 2026, the Court held that forthwith does not mean immediately, so the 2 day gap was not undue, and found that the managing partner was prima facie involved in the firm’s daily affairs. The Court observed that the allegations bear directly on public health, and the matter will go to trial. The ruling is relevant to drug manufacturers and their partners or directors facing quality-related prosecution, particularly on sample handling and personal liability.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.